Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Neurones Forward PE Ratio Related Terms
Neurones Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Neurones's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neurones Forward PE Ratio Chart
Neurones Annual Data
Trend
2024-12
2025-12
Forward PE Ratio
20.05
18.52
Neurones Semi-Annual Data
2024-12
2025-06
2025-12
Forward PE Ratio
20.05
20.73
18.52
XPAR:NRO vs IBM, ACN, FISV: Forward PE Ratio Comparison
For the Information Technology Services subindustry, Neurones's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neurones Forward PE Ratio vs Software Industry
For the Software industry and Technology sector, Neurones's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Neurones's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Neurones (XPAR:NRO) has a Forward PE Ratio of 15.22 as of Jul. 28, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Neurones and its competitors. According to the industry distribution chart, Neurones ranks #466 out of 1173 companies in the Software industry, placing it in the top 39.7%.
Is Neurones' Forward PE Ratio too high?
Neurones' current Forward PE Ratio is 15.22. The Software industry median Forward PE Ratio is 18.61. Neurones' value of 15.22 is 18.2% below this industry median. Based on the distribution chart, Neurones ranks #466 out of 1173 companies in the Software industry, which is above the industry midpoint. Overall, Neurones has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neurones' Forward PE Ratio compare to IBM and ACN?
According to the Software industry distribution chart, Neurones ranks #466 out of 1173 companies for Forward PE Ratio. This puts Neurones in the upper half of its industry. The industry median Forward PE Ratio is 18.61. Neurones' value of 15.22 is 18.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Software company?
The median Forward PE Ratio among Software companies is 18.61, based on 1,173 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Neurones's current Forward PE Ratio of 15.22 is 18.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Neurones and its competitors. For the Software industry, the median Forward PE Ratio is 18.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neurones's current Forward PE Ratio is 15.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neurones stock overvalued right now?
Based on GuruFocus' analysis, Neurones (XPAR:NRO) is currently considered Modestly Undervalued. The stock's GF Value™ is €50.47, compared to a current price of €36.40 — trading 27.9% below its estimated fair value. The current Forward PE Ratio is 15.22 and 18.2% below the Software industry median of 18.61. Neurones' overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Neurones (XPAR:NRO), the current Forward PE Ratio is 15.22 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Neurones (XPAR:NRO) Overvalued in 2026?
Based on GuruFocus' analysis, Neurones stock appears to be undervalued.
The current stock price of €36.40 is trading 27.9% below its estimated GF Value™ of €50.47.
GuruFocus considers Neurones to be Modestly Undervalued.
Key valuation signals for XPAR:NRO:
Forward PE Ratio: 15.22
GF Value™: €50.47 vs. price of €36.40 (27.9% below fair value)
Industry Position: 18.2% below the Software median (#466 of 1173)
No single metric tells the full story. See the XPAR:NRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Neurones is active in Consulting and Digital Services, with activities including Digital Transformation, Overall Offer, Infrastructure Hub, Applications Hub, Consulting Division, Managed Services, and Service Centers. It also conducts IT development, pre-sales activities, management of fixed-price projects, technical assistance, infrastructure operations, and cybersecurity, and provides an internal platform for multi-LLM assistants, including Microsoft Copilot, ChatGPT, Gemini, Claude, and Mistral. Its segments are Infrastructure Services, Application Services, and Consulting. Infrastructure Services generates the majority of revenue and includes Cloud, Infrastructure Management, DevOps, Cybersecurity, User Support, IT Service Management, Information System Governance, and Automation.
91GF Score
Get the complete analysis for XPAR:NRO
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:NRO has been successfully added to your 
